Key Details
Price
$812.03Last Dividend
$1.30Annual ROE
48.43%Beta
0.78Events Calendar
Next earnings date:
Feb 06, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Feb 06, 2024Next ex-dividend date:
Feb 14, 2025Recent ex-dividend date:
Nov 15, 2024Next split:
N/ARecent split:
Oct 16, 1997Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Eli Lilly (LLY) will announce its fourth-quarter earnings on Thursday morning, and analysts predict an increase in both sales and profits. This will be the first complete quarter since the company’s weight-loss medications were confirmed to be available again.
Some friends are only there for good times, while others stay for life. The same can be said about stocks.
In the last six months, Eli Lilly (LLY -1.48%) has not performed as well as the overall stock market. Although this isn't a major concern in the bigger picture, it is somewhat unexpected because the company is a top player in the promising weight loss drug market.
We have just put together a list of the 12 Best Big Name Stocks to Invest in Right Now. In this article, we will examine how Eli Lilly and Company (NYSE:LLY) compares to other top big name stocks available for investment. Big name stocks are well-known companies that are easily recognized and...
We have just released a list of the 12 Best Stocks for Beginners to Buy in 2025. In this article, we will examine how Eli Lilly and Company (NYSE:LLY) compares to other top beginner stocks for 2025. Additionally, we will discuss the stock market predictions for 2025, as shared by Tom Lee from Fundstrat Global on December 12.
I believe that the stock correction for Eli Lilly and Company might be coming to an end because the demand for their important drugs, Zepbound and Mounjaro, is still strong, even with recent cuts in sales forecasts. The company's high valuation is supported by strong growth expectations for the fiscal years 2025 and 2026, and possibly beyond. However, there are risks from competition with Novo Nordisk and possible pricing pressures that could affect profit margins and the stock's value.
Lilly (LLY) has recently caught the attention of many Zacks.com users. Therefore, it's important to look into what the future holds for this stock.
Many individuals set a New Year's resolution to enhance their financial situation by investing in stocks. This is a commendable aim, and to begin, it's important to choose stocks that have the potential to succeed over the long term.
Currently, it is not the largest publicly traded company in the world. That title still goes to Apple, which has a market value of nearly $3.5 trillion.
Eli Lilly (NYSE: LLY) shares performed well on Friday, increasing by over 2%. This rise was mainly influenced by news from a competitor, Novo Nordisk (NYSE: NVO), which is also successfully selling a weight loss drug called Wegovy that competes with Eli Lilly's Zepbound.
FAQ
- What is the primary business of Eli Lilly and Company?
- What is the ticker symbol for Eli Lilly and Company?
- Does Eli Lilly and Company pay dividends?
- What sector is Eli Lilly and Company in?
- What industry is Eli Lilly and Company in?
- What country is Eli Lilly and Company based in?
- When did Eli Lilly and Company go public?
- Is Eli Lilly and Company in the S&P 500?
- Is Eli Lilly and Company in the NASDAQ 100?
- Is Eli Lilly and Company in the Dow Jones?
- When was Eli Lilly and Company's last earnings report?
- When does Eli Lilly and Company report earnings?
- Should I buy Eli Lilly and Company stock now?